Publications by authors named "James D Rodgers"

Claim this Profile
P
Preclinical evaluation of local JAK1 and JAK2 inhibition in cutaneous inflammation.
Jordan S Fridman, Peggy A Scherle, Robert Collins, Timothy Burn, Claire L Neilan, James D Rodgers

J Invest Dermatol· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective inhibition of JAK1 and JAK2 is efficacious in rodent models of arthritis: preclinical characterization of INCB028050.
Jordan S Fridman, Peggy A Scherle, Robert Collins, Timothy C Burn, Yanlong Li, James D Rodgers

J Immunol· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical characterization of the selective JAK1/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasms.
Alfonso Quintás-Cardama, Kris Vaddi, Phillip Liu, Taghi Manshouri, Jun Li, James D Rodgers

Blood· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined inhibition of Janus kinase 1/2 for the treatment of JAK2V617F-driven neoplasms: selective effects on mutant cells and improvements in measures of disease severity.
Phillip C C Liu, Eian Caulder, Jun Li, Paul Waeltz, Alex Margulis, James D Rodgers

Clin Cancer Res· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differentiating nursing leadership and management competencies.
Bonnie Mowinski Jennings, Cynthia C Scalzi, James D Rodgers, Anne Keane

Nurs Outlook· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of second generation quinazolinone non-nucleoside reverse transcriptase inhibitors of HIV-1.
Jeffrey W Corbett, James D Rodgers

Prog Med Chem· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis